Debt-to-equity of NEKTAR THERAPEUTICS from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NEKTAR THERAPEUTICS quarterly Debt-to-equity in % history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • NEKTAR THERAPEUTICS Debt-to-equity for the quarter ending 30 Sep 2025 was 690%, a 152% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NEKTAR THERAPEUTICS Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 690% +416% +152% 30 Sep 2025
Q2 2025 985% +767% +352% 30 Jun 2025
Q1 2025 497% +315% +173% 31 Mar 2025
Q4 2024 328% +167% +104% 31 Dec 2024
Q3 2024 274% +145% +112% 30 Sep 2024
Q2 2024 218% +109% +99% 30 Jun 2024
Q1 2024 182% +85% +87% 31 Mar 2024
Q4 2023 160% +77% +93% 31 Dec 2023
Q3 2023 129% +54% +71% 30 Sep 2023
Q2 2023 109% +41% +61% 30 Jun 2023
Q1 2023 97% +37% +62% 31 Mar 2023
Q4 2022 83% +29% +52% 31 Dec 2022
Q3 2022 75% +26% +53% 30 Sep 2022
Q2 2022 68% +26% +63% 30 Jun 2022
Q1 2022 60% +24% +69% 31 Mar 2022
Q4 2021 54% +18% +51% 31 Dec 2021
Q3 2021 49% +14% +38% 30 Sep 2021
Q2 2021 42% +3% +8% 30 Jun 2021
Q1 2021 36% -5% -11% 31 Mar 2021
Q4 2020 36% -1% -2.5% 31 Dec 2020
Q3 2020 36% +3% +8.9% 30 Sep 2020
Q2 2020 39% +9% +31% 30 Jun 2020
Q1 2020 40% +13% +50% 31 Mar 2020
Q4 2019 37% +4% +12% 31 Dec 2019
Q3 2019 33% -14% -29% 30 Sep 2019
Q2 2019 29% -57% -66% 30 Jun 2019
Q1 2019 27% -756% -97% 31 Mar 2019
Q4 2018 33% -819% -96% 31 Dec 2018
Q3 2018 47% -831% -95% 30 Sep 2018
Q2 2018 87% -2735% -97% 30 Jun 2018
Q1 2018 783% -6822% -90% 31 Mar 2018
Q4 2017 852% +11074% 31 Dec 2017
Q3 2017 878% +2839% 30 Sep 2017
Q2 2017 2821% -29028% -91% 30 Jun 2017
Q1 2017 7605% +5343% +236% 31 Mar 2017
Q4 2016 -10222% -11328% -1024% 31 Dec 2016
Q3 2016 -1961% -2844% -322% 30 Sep 2016
Q2 2016 31849% +30992% +3618% 30 Jun 2016
Q1 2016 2262% +851% +60% 31 Mar 2016
Q4 2015 1106% -3702% -77% 31 Dec 2015
Q3 2015 883% +3119% 30 Sep 2015
Q2 2015 857% +1919% 30 Jun 2015
Q1 2015 1411% +2412% 31 Mar 2015
Q4 2014 4808% +5823% 31 Dec 2014
Q3 2014 -2236% +1617% +42% 30 Sep 2014
Q2 2014 -1062% -2878% -158% 30 Jun 2014
Q1 2014 -1001% -1694% -245% 31 Mar 2014
Q4 2013 -1015% -1465% -326% 31 Dec 2013
Q3 2013 -3853% -4180% -1278% 30 Sep 2013
Q2 2013 1816% +1554% +593% 30 Jun 2013
Q1 2013 692% +481% +228% 31 Mar 2013
Q4 2012 450% +276% +159% 31 Dec 2012
Q3 2012 327% +129% +65% 30 Sep 2012
Q2 2012 262% 30 Jun 2012
Q1 2012 211% 31 Mar 2012
Q4 2011 174% 31 Dec 2011
Q3 2011 198% 30 Sep 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.